LinkedIn Profile

Access Apollo Endosurgery historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:apen 267340 Apr 28th, 2024 12:00AM Apollo Endosurgery 20K 196.00 Open Apr 27th, 2024 10:45PM Apr 27th, 2024 10:45PM Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon. Open medical device, weightloss, minimally invasive surgery, and endoscopic Open 1120 S. Capital of Texas Highway Austin TX US 78746 Apollo Endosurgery
nasdaq:apen 8354343 Apr 28th, 2024 12:00AM LPATH THERAPEUTICS INC. 83 4.00 Open Apr 27th, 2024 10:45PM Apr 27th, 2024 10:45PM Lpath, Inc. is focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases, including age-related macular degeneration, cancer, and CNS disease. Open Apollo Endosurgery
nasdaq:apen 267340 Apr 27th, 2024 12:00AM Apollo Endosurgery 20K 197.00 Open Apr 26th, 2024 10:35PM Apr 26th, 2024 10:35PM Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon. Open medical device, weightloss, minimally invasive surgery, and endoscopic Open 1120 S. Capital of Texas Highway Austin TX US 78746 Apollo Endosurgery
nasdaq:apen 8354343 Apr 27th, 2024 12:00AM LPATH THERAPEUTICS INC. 83 4.00 Open Apr 26th, 2024 10:35PM Apr 26th, 2024 10:35PM Lpath, Inc. is focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases, including age-related macular degeneration, cancer, and CNS disease. Open Apollo Endosurgery
nasdaq:apen 8354343 Apr 26th, 2024 12:00AM LPATH THERAPEUTICS INC. 83 4.00 Open Apr 25th, 2024 10:42PM Apr 26th, 2024 08:02AM Lpath, Inc. is focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases, including age-related macular degeneration, cancer, and CNS disease. Open Apollo Endosurgery
nasdaq:apen 267340 Apr 26th, 2024 12:00AM Apollo Endosurgery 20K 197.00 Open Apr 25th, 2024 10:42PM Apr 26th, 2024 08:02AM Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon. Open medical device, weightloss, minimally invasive surgery, and endoscopic Open 1120 S. Capital of Texas Highway Austin TX US 78746 Apollo Endosurgery
nasdaq:apen 267340 Apr 25th, 2024 12:00AM Apollo Endosurgery 20K 198.00 Open Apr 24th, 2024 10:36PM Apr 25th, 2024 06:15PM Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon. Open medical device, weightloss, minimally invasive surgery, and endoscopic Open 1120 S. Capital of Texas Highway Austin TX US 78746 Apollo Endosurgery
nasdaq:apen 8354343 Apr 25th, 2024 12:00AM LPATH THERAPEUTICS INC. 83 4.00 Open Apr 24th, 2024 10:36PM Apr 25th, 2024 06:15PM Lpath, Inc. is focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases, including age-related macular degeneration, cancer, and CNS disease. Open Apollo Endosurgery
nasdaq:apen 267340 Apr 24th, 2024 12:00AM Apollo Endosurgery 20K 198.00 Open Apr 23rd, 2024 10:41PM Apr 24th, 2024 10:43AM Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon. Open medical device, weightloss, minimally invasive surgery, and endoscopic Open 1120 S. Capital of Texas Highway Austin TX US 78746 Apollo Endosurgery
nasdaq:apen 8354343 Apr 24th, 2024 12:00AM LPATH THERAPEUTICS INC. 83 4.00 Open Apr 23rd, 2024 10:41PM Apr 24th, 2024 10:43AM Lpath, Inc. is focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases, including age-related macular degeneration, cancer, and CNS disease. Open Apollo Endosurgery

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.